Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ertapenem
2. Invanoz
3. Invanz
1. Invanz
2. 153773-82-1
3. Ertapenem Sodium Salt
4. Mk-826
5. Chebi:60070
6. Mk-0826
7. L-749345
8. Invanz (tn)
9. Ertapenem Sodium (usan)
10. Chembl1232
11. Schembl102761
12. Bdbm50248009
13. Mfcd09475566
14. Cs-8020
15. Zd-4433
16. As-84039
17. Hy-13625
18. D04049
19. Sodium 3-((2s,4s)-4-(((4r,5s,6s)-2-carboxy-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl)thio)pyrrolidine-2-carboxamido)benzoate
20. Sodium 3-[(2s,4s)-4-{[(4r,5s,6s)-2-carboxy-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl}pyrrolidine-2-amido]benzoate
21. Sodium;3-[[(2s,4s)-4-[[(4r,5s,6s)-2-carboxy-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl]pyrrolidine-2-carbonyl]amino]benzoate
| Molecular Weight | 497.5 g/mol |
|---|---|
| Molecular Formula | C22H24N3NaO7S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 497.12326557 g/mol |
| Monoisotopic Mass | 497.12326557 g/mol |
| Topological Polar Surface Area | 184 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 900 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
* Treatment:
Treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required:
- intra-abdominal infections;
- community-acquired pneumonia;
- acute gynaecological infections;
- diabetic foot infections of the skin and soft tissue.
* Prevention:
Invanz is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01DH03
ABOUT THIS PAGE
A 153773-82-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 153773-82-1, including repackagers and relabelers. The FDA regulates 153773-82-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 153773-82-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 153773-82-1 supplier is an individual or a company that provides 153773-82-1 active pharmaceutical ingredient (API) or 153773-82-1 finished formulations upon request. The 153773-82-1 suppliers may include 153773-82-1 API manufacturers, exporters, distributors and traders.
153773-82-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 153773-82-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 153773-82-1 GMP manufacturer or 153773-82-1 GMP API supplier for your needs.
A 153773-82-1 CoA (Certificate of Analysis) is a formal document that attests to 153773-82-1's compliance with 153773-82-1 specifications and serves as a tool for batch-level quality control.
153773-82-1 CoA mostly includes findings from lab analyses of a specific batch. For each 153773-82-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
153773-82-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (153773-82-1 EP), 153773-82-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (153773-82-1 USP).
LOOKING FOR A SUPPLIER?
